{"database": "lobbying", "table": "lobbying_activities", "rows": [[2148192, "3410753d-cc8a-4763-a69c-3285f38e0040", "Q2", "CARMEN GROUP INCORPORATED", 8316, "BIOREFERENCE LABORATORIES, INC.", 2018, "second_quarter", "MED", "Delaying implementation of the Clinical Laboratory Fees Schedule; Support Local Coverage Determination process legislation; Concern about FDA regulation of clinical labs; Authorization of the 4K score test for prostrate cancer; MAC review of lab testing; National Coverage decision on genetic testing.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 45000, null, 0, 0, "2018-07-17T16:16:28.847000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2148192"], "units": {}, "query_ms": 13.912845985032618, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}